author
equal
contribut
content
manuscript
multipl
sclerosi
inflammatori
demyelin
diseas
central
nervou
system
hallmark
patholog
h
e
demyelin
plaqu
reactiv
glial
scar
format
howev
detail
analysi
pattern
demyelin
oligodendroglia
cell
patholog
reaction
tissu
compon
suggest
pathogenesi
myelin
destruct
n
diseas
may
heterogen
review
w
e
present
new
classif
scheme
lesion
activ
basi
molecular
composit
myelin
degrad
product
macrophag
criteria
use
differ
pattern
demyelin
distinguish
includ
demyelin
rel
preserv
oligodendrocyt
myelin
destruct
concomit
complet
destruct
oligodendrocyt
primari
destruct
disturb
myelin
cell
secondari
demyelin
furthermor
case
primari
select
demyelin
may
follow
secondari
oligodendrocyt
loss
establish
lesion
final
extraordinarili
sever
condit
may
result
destruct
lesion
loss
myelin
oligodendrocyt
axon
astrocyt
heterogen
plaqu
patholog
discuss
n
context
recent
experiment
model
inflammatori
demyelin
show
h
differ
immunolog
pathway
may
lead
format
demyelin
plaqu
reveal
divers
structur
aspect
describ
data
indic
h
e
demyelin
plaqu
multipl
sclerosi
may
reflect
common
patholog
end
point
varieti
differ
immunolog
mechan
myelin
destruct
diseas
multipl
sclerosi
inflammatori
demyelin
diseas
central
nervou
system
hallmark
patholog
h
e
demyelin
plaqu
reactiv
glial
scar
format
howev
detail
analysi
pattern
demyelin
oligodendroglia
cell
patholog
reaction
tissu
compon
suggest
pathogenesi
myelin
destruct
n
diseas
may
heterogen
review
w
e
present
new
classif
scheme
lesion
activ
basi
molecular
composit
myelin
degrad
product
macrophag
criteria
use
differ
pattern
demyelin
distinguish
includ
demyelin
rel
preserv
oligodendrocyt
myelin
destruct
concomit
complet
destruct
oligodendrocyt
primari
destruct
disturb
myelin
cell
secondari
demyelin
furthermor
case
primari
select
demyelin
may
follow
secondari
oligodendrocyt
loss
establish
lesion
final
extraordinarili
sever
condit
may
result
destruct
lesion
loss
myelin
oligodendrocyt
axon
astrocyt
heterogen
plaqu
patholog
discuss
n
context
recent
experiment
model
inflammatori
demyelin
show
h
differ
immunolog
pathway
may
lead
format
demyelin
plaqu
reveal
divers
structur
aspect
describ
data
indic
h
e
demyelin
plaqu
multipl
sclerosi
may
reflect
common
patholog
end
point
varieti
differ
immunolog
mechan
myelin
destruct
diseas
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
associ
focal
destruct
myelin
sheath
astrocyt
scar
format
patholog
hallmark
ms
white
matter
plaqu
wide
scatter
throughout
central
nervou
system
cn
predilect
optic
nerv
brainstem
spinal
cord
periventricular
white
matter
despit
extens
research
etiolog
unknown
natur
histori
unpredict
current
cure
furthermor
neuropatholog
studi
ms
base
examin
plaqu
late
stage
diseas
minim
data
regard
featur
associ
initi
develop
acut
lesion
recent
studi
suggest
pattern
inflamm
demyelin
oligodendrocyt
destruct
may
vari
individu
ms
patient
indic
pathogenet
mechan
lead
demyelin
may
fundament
differ
distinct
subtyp
diseas
although
gener
accept
immun
system
contribut
tissu
destruct
ms
still
unclear
whether
immun
respons
trigger
damag
consequ
diseas
process
addit
debat
compon
immun
system
key
player
ms
investig
emphas
role
lymphocyt
induc
inflamm
demyelin
howev
contribut
cell
microgliamacrophag
astrocyt
cytokin
antibodi
complement
receiv
increas
attent
although
current
concept
base
assumpt
ms
caus
singl
pathogenet
mechan
extens
vivo
vitro
data
indic
mani
differ
toxic
immunolog
mechan
may
ultim
lead
select
destruct
myelin
sheath
oligodendrocyt
pathogenet
divers
may
also
reflect
appar
multitud
suscept
gene
identifi
recent
genet
epidemiolog
studi
ms
final
recent
serial
mri
studi
togeth
mri
spectroscopi
provid
better
insight
dynam
evolut
ms
plaqu
also
suggest
differ
extent
inflammatori
activ
blood
brain
barrier
disturb
tissu
damag
differ
clinic
manifest
diseas
issu
stress
need
reevalu
multipl
sclerosi
patholog
particular
emphasi
defin
immunopatholog
event
occur
activ
demyelin
lesion
essenti
provid
precis
definit
lesion
activ
criteria
identif
activ
lesion
literatur
controversi
often
mislead
tabl
summar
exist
criteria
base
upon
myelin
degrad
product
within
macrophag
inflammatori
activ
presenc
gadolinium
enhanc
mri
use
frequent
clinician
major
criteria
defin
lesion
activ
thought
reflect
bloodbrainbarri
bbb
damag
although
consid
one
earliest
chang
observ
ms
lesion
neuropatholog
immunocytochem
studi
reveal
bbb
leakag
found
variabl
degre
everi
ms
lesion
includ
inact
demyelin
plaqu
patholog
find
appear
disagr
recent
mri
investig
found
gddtpa
leakag
restrict
activ
ms
lesion
discrep
may
relat
low
sensit
mri
techniqu
detect
bbb
dysfunct
correl
studi
reveal
gdenhanc
mri
lesion
correspond
inflammatori
infiltr
primarili
macrophag
accompani
edema
myelin
destruct
alway
present
furthermor
presenc
bbb
damag
patholog
condit
without
evid
demyelin
mening
enceph
impli
nonspecif
cell
respons
alon
suffici
produc
demyelin
attempt
also
made
defin
inflammatori
activ
within
lesion
base
upon
infiltr
vessel
wall
spread
cn
parenchyma
inflammatori
cell
upregul
adhes
molecul
mhc
antigen
product
cytokin
definit
activ
stage
macrophag
lesion
result
inconclus
sinc
chronic
inflammatori
process
ms
upregul
immun
associ
molecul
rather
matter
quantiti
qualiti
spectrum
cytokin
express
broad
activ
plaqu
often
defin
presenc
cholesterol
ester
neutral
lipid
macrophag
stain
lipophil
dye
oil
red
sudan
although
suitabl
techniqu
easili
appli
fresh
formaldehyd
fix
tissu
sudanophil
stage
myelin
degrad
may
persist
sever
month
destruct
myelin
sheath
therefor
observ
may
reflect
accur
earli
stare
diseas
evolut
better
definit
demyelin
activ
within
plaqu
obtain
studi
structur
profil
chemic
composit
myelin
degrad
product
within
macrophag
examin
express
inflammatori
macrophag
activ
antigen
lesion
time
sequenc
myelin
degrad
macrophag
found
monophas
experiment
human
lesion
studi
minor
myelin
protein
myelin
oligodendrocyt
glycoprotein
mog
myelin
associ
glycoprotein
mag
rapidli
degrad
within
macrophag
within
day
phagocytosi
contrast
major
myelin
protein
myelin
basic
protein
mbp
proteolipid
protein
plp
may
persist
macrophag
day
later
stage
macrophag
contain
sudanophil
pasposit
granular
lipid
may
persist
lesion
sever
month
recent
studi
provid
evid
differenti
pattern
macrophag
activ
ms
lesion
obtain
earli
cours
diseas
studi
differ
pattern
macrophag
activ
differenti
ms
lesion
identifi
use
panel
antibodi
recogn
formalinresist
macrophagedifferenti
antigen
pattern
correl
stage
demyelin
activ
detect
presenc
myelin
degrad
product
overal
number
macrophag
highest
lesion
ongo
activ
demyelin
shown
use
panmacrophag
marker
correl
also
found
express
macrophag
activ
antigen
stage
demyelin
activ
acut
stage
inflammatori
marker
select
express
earli
earli
late
activ
lesion
contrast
chronic
stage
inflammatori
macrophag
marker
show
increas
express
decreas
lesion
activ
find
demonstr
sequenti
express
macrophag
activ
antigen
ms
lesion
thu
provid
paramet
defin
activ
ms
plaqu
tabl
illustr
one
current
classif
scheme
defin
lesion
activ
basi
myelin
degrad
product
within
macrophag
macrophag
activ
marker
although
gener
accept
definit
ms
plaqu
activ
literatur
classif
scheme
provid
uniform
approach
futur
pathogenet
studi
controversi
surround
natur
initi
patholog
chang
ms
although
chronic
persist
inflamm
cn
consid
one
characterist
featur
ms
patholog
remain
unclear
whether
inflamm
primari
secondari
phenomenon
lesion
evolut
seitelberg
lumsden
allen
seitelberg
lumsden
guseo
jelling
li
sander
adam
lassmann
prinea
yao
ozawa
ozawa
traugott
hay
li
sander
bruck
lumsden
prinea
guseo
jelling
rain
li
sander
traugott
selmaj
canella
brosnan
sobel
washington
canella
sobel
investig
suggest
perivascular
lymphocyt
reaction
initi
demyelin
process
would
impli
immunolog
activ
cell
enter
cn
via
activ
endotheliurn
myelin
would
destroy
either
nonspecif
reaction
releas
iymphokin
antigenspecif
mechan
sever
line
evid
support
primari
natur
inflammatori
process
ms
experiment
allerg
encephalomyel
lymphocyt
adher
postcapillari
venul
subsequ
migrat
across
endothelium
perivascular
space
cn
parenchyma
preced
demyelin
perivascular
inflammatori
infiltr
typic
present
ms
lesion
area
activ
myelin
breakdown
inflammatori
reaction
activ
ms
lesion
associ
local
upregul
immunoregulatori
molecul
histocompat
antigen
cytokin
adhes
molecul
chemokin
suggest
contribut
role
inflammatori
respons
diseas
immunocytochem
studi
demonstr
leakag
immunoglobulin
complement
capillari
venul
edg
activ
plaqu
evid
damag
vessel
wall
serial
mri
studi
reveal
clinic
ms
exacerb
gener
associ
focal
bbb
damag
although
evid
support
primari
inflammatori
attack
myelin
sever
key
point
worth
note
neuropatholog
studi
reveal
inflammatori
cell
specif
cell
alway
present
area
activ
demyelin
ultrastructur
studi
stereotact
brain
biopsi
specimen
patholog
consist
ms
reveal
evid
myelin
degener
outsid
area
maxim
inflamm
macrophag
infiltr
suggest
demyelina
inact
earli
remyel
late
remyel
although
macrophag
contain
myelin
debri
within
cytoplasm
observ
could
interpret
consequ
rather
caus
myelin
degrad
sinc
similar
pattern
macrophag
activ
observ
condit
associ
myelin
destruct
addit
ct
mri
enhanc
correl
extens
macrophag
infiltr
lymphocyt
invas
upregul
mhc
class
express
activ
lesion
locat
pericyt
perivascular
macrophag
microglia
astrocyt
restrict
immunemedi
condit
diseas
link
cell
dysfunct
trauma
infarct
neurodegen
diseas
alzheim
diseas
also
associ
class
mhc
express
final
silent
plaqu
lack
lymphocyt
infiltr
also
express
abund
class
macrophag
knowledg
ms
neuropatholog
base
upon
studi
late
chronic
ms
lesion
character
sharpli
demarc
area
myelin
sheath
select
destroy
rel
axon
preserv
dens
glial
scar
format
addit
old
sclerot
plaqu
may
activ
lesion
ongo
myelin
destruct
mani
differ
theori
propos
explain
process
demyelin
ms
babinski
first
describ
interact
debri
contain
cell
demyelin
fiber
emphas
central
role
leukocyt
myelin
destruct
marburg
hand
describ
lysi
myelin
follow
infiltr
phagocyt
cell
postul
pathogenet
role
humor
myelinotox
factor
base
upon
ultrastructur
studi
sever
pattern
demyelin
describ
receptormedi
phagocytosi
myelin
pinocytosi
vermiformi
pattern
interact
coat
pit
vesicl
macrophag
myelin
sheath
found
macrophag
thought
react
opson
myelin
fc
complement
receptor
express
high
densiti
macrophag
cell
surfac
activ
lesion
myelin
ingest
macrophag
vesicl
tubular
channel
view
support
demonstr
igg
deposit
site
macrophagemyelin
interact
b
myelin
strip
pattern
lymphocyt
macrophag
invad
myelin
sheath
found
either
myelin
lamella
myelin
sheath
axon
disorgan
vesicular
dissolut
myelin
present
vicin
inflammatori
cell
although
common
pattern
seen
eae
model
appear
rel
rare
ms
found
mainli
lesion
acut
ms
promin
inflammatori
infiltr
c
vesicular
disrupt
myelin
sheath
vesicular
transform
part
sheath
even
whole
myelin
found
mainli
acut
ms
case
character
sever
destruct
lesion
howev
minor
degre
also
describ
chronic
activ
ms
plaqu
promin
pattern
experiment
model
demyelin
lesion
mediat
antibodi
complement
although
clear
experiment
studi
pattern
demyelin
may
occur
vivo
human
autopsi
tissu
process
may
exagger
post
mortem
autolysi
die
back
oligodendrogliopathi
hallmark
pattern
character
patholog
alter
distal
extens
oligodendroglia
cell
process
initi
describ
model
toxic
oligodendrogliopathi
demyelin
recent
also
report
featur
brain
biopsi
obtain
earli
phase
diseas
pattern
oligodendrocyt
damag
report
virusinduc
model
demyelin
similar
alter
observ
mag
defici
mice
unpublish
observ
chang
die
back
oligodendrogliopathi
may
reflect
impair
oligodendrocyt
metabol
ms
lesion
sinc
myelin
gene
express
oligodendrocyt
may
downregul
face
viral
infect
inflamm
well
ms
case
certain
whether
alter
invari
lead
oligodendrocyt
destruct
unfortun
ultrastructur
studi
base
small
number
case
confirm
common
mechan
myelin
destruct
patient
furthermor
studi
resolv
ongo
debat
whether
myelin
sheath
oligodendrocyt
primari
target
immunemedi
injuri
ms
case
typic
chronic
ms
investig
agre
oligodendrocyt
larg
absent
lesion
matter
less
clear
regard
fate
oligodendrocyt
earli
stage
multipl
sclerosi
light
microscop
electron
microscop
immunocytochem
studi
report
variabl
degre
oligodendrocyt
preserv
activ
demyelin
lesion
prinea
immunocytochem
examin
fresh
cn
lesion
patient
earli
ms
observ
strike
loss
oligodendrocyt
activ
diseas
fpllow
recruit
larg
number
undifferenti
oligodendrocyt
progenitor
thought
repopul
plaqu
final
number
oligodendrocyt
within
lesion
would
depend
upon
avail
oligodendrocyt
progenitor
cell
rain
et
selmaj
hand
describ
high
number
oligodendrocyt
earli
activ
lesion
howev
cell
subsequ
destroy
diseas
progress
author
suggest
oligodendrocyt
surviv
initi
attack
later
destroy
via
addit
immunemedi
mechan
rodriguez
propos
oligodendrocyt
may
morpholog
preserv
acut
lesion
cell
function
properli
base
alter
observ
inner
glial
loop
distal
extens
oligodendrogli
membran
therefor
luxuri
function
cell
ie
myelin
may
disrupt
without
death
cell
lassmann
et
propos
degre
oligodendrocyt
patholog
may
differ
earli
late
stage
ms
well
differ
patient
order
draw
meaning
conclus
fate
oligodendrocyt
radial
expand
ms
lesion
essenti
correl
oligodendrocyt
number
stage
myelin
degrad
product
macrophag
howev
previou
neuropatholog
studi
limit
due
small
number
suitabl
case
lesion
difficulti
identifi
oligodendrocyt
within
tissu
section
use
well
defin
criteria
lesion
activ
sever
studi
reli
upon
indirect
criteria
oligodendrocyt
identif
presenc
cell
typic
oligodendrocyt
morpholog
stain
macrophagemicroglia
marker
round
cell
larger
leukocyt
furthermor
prior
immunocytochem
marker
use
ms
tissu
stain
myelin
antigen
express
oligodendrocyt
peak
mye
inationremyelin
recent
develop
techniqu
better
allow
patholog
oligodendrocyt
pattern
oligodendrocyt
death
systemat
studi
activ
demyelin
ms
lesion
identifi
oligodendrocyt
use
two
marker
presenc
proteolipid
protein
plp
mrna
within
cell
express
myelin
oligodendrocyt
glycoprotein
mog
surfac
siki
hybrid
plp
mrna
earli
marker
oligodendrocyt
differenti
allow
identif
oligodendrocyt
engag
myelin
mainten
synthesi
mog
protein
appear
surfac
oligodendrocyt
myelin
late
myelin
myelin
demyelin
lesion
protein
preserv
surfac
oligodendrocyt
use
identifi
termin
differenti
oligodendrocyt
within
ms
plaqu
marker
combin
dna
fragment
tissu
section
identifi
cell
degener
within
activ
ms
lesion
ms
materi
includ
studi
ozawa
includ
paraffin
embed
biopsi
autopsi
tissu
case
clinic
andlor
autopsi
proven
multipl
sclerosi
case
group
three
categori
anit
multipl
sclerosi
case
defin
accord
marburg
criteria
character
clinic
sever
relentlessli
progress
relaps
neurolog
diseas
lead
death
within
one
year
onset
ii
earli
multipl
sclerosi
specimen
consist
stereotact
biopsi
patient
first
second
bout
diseas
month
diseas
onset
patient
follow
addit
year
iii
late
multipl
sclerosi
group
consist
patient
chronic
relaps
chronic
progress
diseas
year
imrnunocytochernistri
plp
protein
red
e
rernyelin
lesion
mogposit
oligodendrocyt
arrowhead
immunocytochemistri
mog
f
rernyelin
shadow
plaqu
numer
oligodendrocyt
contain
plp
mrna
situ
hybrid
plp
mrna
black
irnmunocytochernistri
plp
protein
red
diseas
total
thirtysix
region
examin
classifi
respect
demyelin
activ
base
upon
profii
rnyelin
degrad
proda
parallel
studi
briick
et
al
focus
specif
patholog
earli
ms
seen
biopsi
taken
first
second
attack
figur
activ
dernyelin
associ
oligodendrocyt
loss
ms
oligodendrocyt
loss
incomplet
dernyelin
plaqu
b
compar
periplaqu
white
matter
situ
hybrid
plp
rnrna
black
imrnunocytochernistri
plp
protein
red
b
high
power
magnif
plaqu
show
strike
loss
oligodendrocyt
situ
hybrid
plp
mrna
black
imrnunocytochemistri
plp
protein
red
c
rare
oligodendrocyt
present
within
activ
demyelin
plaqu
arrow
immunocytochernistri
mog
extens
macrophag
infiltr
throughout
lesion
irnmunocytochemistri
panmacrophag
marker
p
e
high
power
magnif
extens
macrophag
infiltr
irnmunocytochemistri
p
f
express
macrophag
earli
activ
ms
lesion
irnmunocytochemistri
uct
within
cytoplasm
macrophag
sumearli
exacerb
ms
select
demyelin
mariz
tabl
associ
almost
complet
preserv
pattern
demyelin
three
cateoligodendrocyt
high
number
remyelinatgori
acut
earli
late
character
conflu
lesion
lesion
occur
late
chronic
ent
plaqu
inflammatori
reaction
ms
demyelin
accompani
extens
domin
lymphocyt
macrophag
destruct
loss
oligodendrocyt
signific
increas
number
immunogloburemyelin
spars
case
lin
produc
plasma
cell
present
inflammamarburg
type
acut
ms
demyelin
assotori
infiltr
late
chronic
ms
lesion
ciat
extens
destruct
oligodendro
cyte
astrocyt
axon
howev
consider
number
oligodendrocyt
preserv
capabl
remyelin
data
suggest
major
acut
earli
ms
lesion
oligodendrocyt
larg
preserv
howev
late
chronic
lesion
select
destruct
oligodendrocyt
associ
demyelin
high
number
plasma
cell
found
cn
patient
late
chronic
ms
may
indic
pathogenet
role
antibodi
demyelin
oligodendrogli
destruct
may
repres
n
attempt
antibodi
promot
repair
howev
except
gener
rule
two
seven
earli
multipl
sclerosi
case
demonstr
dramat
loss
oligodendrocyt
three
thirteen
late
chronic
ms
case
reveal
lesion
consider
oligodendrocyt
preserv
loss
preserv
oligodendrocyt
depend
much
stage
lesion
format
suggest
previou
studi
rather
characterist
featur
similar
lesion
lesion
area
given
patient
suggest
given
time
lesion
evolut
pathogenesi
demyelin
process
similar
differ
brain
region
furthermor
one
patient
underw
sequenti
biopsi
earli
phase
diseas
number
oligodendrocyt
within
differ
lesion
similar
find
suggest
pathogenesi
ms
may
vari
differ
patient
may
chang
chronic
diseas
process
pattern
cell
death
also
analyz
use
dnafragment
degener
cell
extens
oligodendrocyt
death
found
border
activ
lesion
chronic
case
typic
die
oligodendrocyt
found
area
demonstr
fundament
differ
pattern
activ
myelin
destruct
find
intercel
death
case
oligodendrocyt
prepret
evid
oligodendrocyt
die
condominantli
destroy
thin
rim
normal
comitantli
myelin
sheath
secondarili
appear
white
matter
immedi
adjac
myelin
destruct
limit
studi
apopact
demyelin
plaqu
edg
pattern
tosi
necrosi
pattern
cell
death
found
suggest
primari
progress
ms
lesion
use
similar
techniqu
collect
three
demyelin
may
occur
secondari
oligodencas
primari
progress
chronic
ms
droglia
damag
observ
need
con
firm
larger
seri
howev
suggest
pathogenesi
primari
progress
ms
may
differ
pathogenesi
relaps
secondarili
progress
diseas
sinc
origin
studi
ozawa
briick
restrict
small
total
number
case
initi
similar
studi
larg
seri
ms
case
collect
mayo
clinic
institut
neuropatholog
gottingen
institut
neurolog
vienna
base
case
brain
biopsi
earli
bout
diseas
avail
autopsi
case
acut
ms
case
chronic
activ
ms
goal
studi
exclud
high
variabl
oligodendrocyt
patholog
previou
studi
ozawa
briick
due
sampl
bia
demyelin
activ
lesion
determin
basi
myelin
degrad
product
macrophag
presenc
earli
macrophag
activ
marker
summar
tabl
preliminari
result
indic
least
five
distinct
pattern
lesion
patholog
discrimin
figur
ms
lesion
myelin
complet
lost
plaqu
activ
myelin
destruct
lesion
border
associ
variabl
minor
reduct
oligodendrocyt
dna
fragment
oligodendrocyt
rare
remyelin
rapid
complet
figur
lesion
activ
demyelin
associ
extens
complet
loss
oligodendrocyt
area
activ
myelin
destruct
mani
cell
dna
fragment
present
express
marker
oligodendrocyt
mog
cnpase
plp
mrna
morpholog
analysi
die
oligodendrocyt
reveal
case
cell
destruct
mediat
apoptosi
wherea
other
particularli
case
high
plasma
cell
densiti
necrosi
domin
inact
plaqu
show
demyelin
extens
glial
scar
limit
remyelin
lesion
similar
first
pattern
describ
oligodendrocyt
densiti
high
area
activ
myelin
breakdown
yet
toward
plaqu
center
progress
reduct
oligodendrocyt
densiti
die
oligodendrocyt
frequent
observ
oiigodendrocyt
loss
mediat
mainli
apoptosi
although
one
case
high
plasma
cell
densiti
necrosi
note
center
plaqu
show
demyelin
glial
scar
without
remyelin
iv
destruct
plaqu
figur
lesion
character
extens
macrophag
infiltr
pronounc
state
activ
compar
previous
report
pattern
widespread
demyelin
parallel
destruct
oligodendrocyt
axon
astrocyt
howev
describ
oligodendrocyt
partli
preserv
even
destruct
area
lesion
pattern
demyelin
particularli
promin
case
marburg
type
acut
multipl
sclerosi
sign
remyelin
present
even
area
activ
myelin
destruct
oligodendrocyt
spars
cell
show
dna
fragment
yet
die
cell
abund
small
zone
periplaqu
white
matter
pattern
demyelin
found
three
autopsi
case
primari
progress
ms
rare
instanc
biopsi
specimen
earli
bout
diseas
pattern
ms
patholog
explain
basi
stage
demyelin
activ
sever
singl
pathogenet
mechan
possibl
multipl
pathogenet
mechan
may
act
parallel
within
lesion
time
lesion
ms
diseas
caus
singi
pathogenet
mechan
one
would
predict
previou
observ
high
variabl
oligodendrocyt
damag
secondari
stagespecif
phenomenon
howev
data
demonstr
correl
observ
pattern
patholog
stage
demyelin
activ
within
lesion
base
upon
macrophag
activ
myelin
degrad
product
furthermor
sirnilar
briick
et
al
initi
observ
smaller
seri
data
confirm
oligodendrocyt
loss
surviv
similar
part
lesion
given
patient
sever
singl
pathogenet
mechan
obvious
sever
pathogenet
process
given
lesion
determin
structur
outcom
mild
form
autoimmun
encephalomyel
select
demyelin
rapid
remyelin
occur
sever
instanc
lead
unselect
tissu
damag
similar
describ
destruct
lesion
yet
alon
explain
ms
lesion
oligodendrocyt
destroy
complet
select
wherea
other
cell
partli
preserv
even
destruct
area
furthermor
preferenti
pattern
oligodendrocyt
destruct
either
apoptosi
necrosi
well
oligodendrocyt
death
occur
either
area
demyelin
periplaqu
white
matter
possibl
simpli
relat
differ
sever
singl
pathogenet
mechan
multipl
mechan
act
parallel
least
two
case
character
progress
loss
oligodendrocyt
toward
plaqu
center
oligodendrocyt
death
occur
via
either
apoptosi
necrosi
seem
independ
demyelin
oligodendrocyt
destruct
occur
plaqu
border
rais
possibl
sever
pathogenet
mechan
act
parallel
within
lesion
howev
major
lesion
examin
individu
patient
follow
distinct
pathogenet
pathway
lesion
format
sinc
differ
pattern
lesion
patholog
differ
ms
case
explain
alon
n
basi
time
sever
singl
pathogenet
pathway
data
suggest
primari
target
demyelin
process
may
vari
individu
patient
thu
may
reflect
distinct
immunopathogenet
mechan
oper
differ
ms
patient
pathogenet
mechan
could
respons
observ
pattern
demyelin
oligodendrocyt
destruct
studi
experiment
anim
model
demyelin
may
provid
import
clue
potenti
pathogenet
mechan
multipl
sclerosi
demyelin
anim
may
produc
immunolog
inject
myelin
compon
transfer
cnsspecif
cell
virus
variou
famili
picornavirus
coronavirus
herp
virus
retrovirus
toxin
lysolecithin
ethidium
bromid
cuprizon
possibl
differ
pattern
oligodendrogli
patholog
demyelin
observ
variou
patient
correl
anim
model
incit
event
immunopathogenet
mechan
better
understood
consid
spectrum
differ
mechan
lead
immun
mediat
demyelin
experiment
model
vivo
vitro
differ
lesion
pattern
describ
unexpect
dernyelin
rel
spare
oligodendrocyt
rapid
remyelin
expect
pattern
pathogenet
process
primarili
direct
myelin
sheath
could
accomplish
bystand
reaction
mediat
immunotoxin
liber
cours
tcell
mediat
inflamm
varieti
immunotoxin
includ
oxygen
radic
tumornecrosi
factor
alpha
lymphotoxin
go
complement
perforin
lyse
preferenti
myelin
oligodendrocyt
vitro
howev
overexagger
toxin
lead
unselect
tissu
damag
similar
observ
destruct
lesion
thu
chronic
model
tcell
mediat
autoimmun
encephalomyel
demyelin
occur
follow
rapid
complet
remyelin
sever
condit
instanc
eae
transgen
anim
overexpress
tnfa
persist
lesion
present
associ
sever
unselect
tissu
damag
anoth
possibl
mechan
myelin
destruct
demyelin
antibodi
act
synergi
tcell
mediat
encephalitogen
respons
present
best
character
target
antigen
demyelin
antibodi
myelin
oligodendrocyt
glycoprotein
mog
mog
strongli
express
extracellular
surfac
myelin
sheath
peripher
oligodendrocyt
process
low
densiti
oligodendrocyt
pericaryon
demyelin
induc
eae
anim
antimog
antibodi
associ
variabl
extent
oligodendrocyt
necrosi
sinc
mog
express
progenitor
cell
rapid
recruit
new
oligodendrocyt
remyelin
occur
repeat
demyelin
episod
mechan
lead
persist
demyelin
lesion
like
due
progress
destruct
matur
immatur
oligodendrocyt
receptormedi
phagocytosi
myelin
cap
surfac
immunoglobulin
g
macrophag
engag
myelin
breakdown
describ
prinea
graham
prinea
multipl
sclerosi
lesion
inde
argu
favor
antibodi
mediat
mechan
furthermor
presenc
plasma
cell
secret
antimog
antibodi
shown
csf
ms
patient
demyelinot
lesion
complet
loss
oligodendrocyt
lack
remyelin
like
due
pathogenet
mechan
elimin
matur
oligodendrocyt
also
effect
destroy
progenitor
pool
although
may
achiev
lesion
repeat
deand
remyelin
occur
chronic
stage
ms
mechan
unlik
oper
similar
lesion
seen
initi
exacerb
diseas
latter
may
either
function
defect
oligodendrocyt
precursor
cell
immun
respons
may
direct
antigen
present
matur
well
immatur
oligodendrocyt
candid
antigen
could
earli
differenti
marker
oligodendrocyt
galactocerebrosid
sulfatid
novel
antigen
peptid
express
follow
viru
infect
theiler
viru
model
multipl
sclerosi
induc
picornaviru
variou
target
cell
oligodendrocyt
astrocyt
macrophag
infect
immun
respons
destroy
oligodendrocyt
prevent
subsequ
remyelin
result
immun
respons
attempt
clear
persist
infect
case
present
gradient
oligodendrocyt
loss
activ
lesion
edg
plaqu
center
indic
multipl
sclerosi
patient
stress
oligodendrocyt
attempt
remyelin
hostil
environ
activ
plaqu
may
becom
target
destruct
mechan
suggest
selmaj
et
describ
intim
contact
gammadelta
lymphocyt
reactiv
oligodendrocyt
plaqu
promin
gammadelta
tcell
respons
observ
activ
ms
lesion
cell
preferenti
lyse
oligodendrocyt
vitro
possibl
recognit
stress
protein
within
ms
lesion
stress
protein
alpha
b
crystallin
upregul
oligodendrocyt
appar
time
begin
remyelin
thu
case
gradient
oligodendroglia
cell
loss
cell
may
escap
primari
demyelin
insult
may
destroy
second
immun
reaction
stress
protein
altern
gradient
loss
oligodendrocyt
could
also
explain
lack
suffici
growth
factor
allow
oligodendrocyt
progenitor
cell
surviv
plaqu
environ
differenti
matur
myelin
cell
line
concept
remyelin
lesion
eae
augment
exogen
applic
insulin
like
growth
factor
igf
furthermor
growth
factor
may
lead
apoptosi
lesion
oligudendrucyt
death
occiir
periplaqu
white
matter
outsid
zone
activ
rnyelin
degener
suggest
subgroup
multipl
sclerosi
patient
primari
oligodendrocyt
destruct
may
lead
secondari
demyelin
one
possibl
mechan
primari
oligodendrocyt
damag
could
persist
viral
infect
cell
popul
varieti
differ
virusinduc
experiment
model
demyelin
avail
show
impair
metabol
function
oligodendrocyt
addit
toxin
interfer
function
oligodendrocyt
could
result
pattern
patholog
sever
studi
demonstr
presenc
viru
antigen
respect
nucleotid
sequenc
multipl
sclerosi
lesion
although
convinc
repeat
demonstr
singl
viru
ms
tissu
still
remain
open
whether
group
persist
viru
infect
may
play
role
subset
ms
patient
primari
damag
oligodendrocyt
seen
lesion
sever
patient
seri
may
support
notion
yet
primari
oligodendrocyt
damag
may
also
occur
immunemedi
condit
dysregul
microglia
macrophag
could
theoret
lead
oligodendrocyt
apoptosi
demyelin
via
free
oxygen
radic
tnfalpha
mediat
injuri
vitro
tnfalpha
produc
oligodendrocyt
destruct
via
apoptosi
l
although
toxic
occur
high
concentr
may
physiolog
conclus
studi
pattern
demyelin
oligodendrocyt
destruct
ms
lesion
underscor
patholog
heterogen
observ
ms
observ
challeng
exist
scientif
dogma
ms
diseas
caus
singl
pathogenet
mechan
rather
suggest
pathogenet
mechan
lead
demyelin
may
fundament
distinct
differ
group
ms
patient
hypothesi
may
part
explain
variabl
clinic
pictur
respect
neurolog
symptom
natur
histori
degre
disabl
seen
diseas
furthermor
genet
studi
support
theori
express
diseas
polygen
control
may
combin
differ
suscept
gene
may
ultim
dictat
patient
immunopathogenet
respons
incit
injuri
account
specif
subtyp
complex
diseas
whether
one
versu
multipl
incit
event
determin
find
may
implic
respect
design
futur
therapeut
strategi
ms
current
reli
upon
larg
placebocontrol
doubleblind
studi
determin
whether
particular
therapi
efficaci
patient
approach
take
account
therapi
may
use
one
group
patient
may
ineffect
possibl
deleteri
anoth
addit
exist
criteria
use
select
patient
suitabl
clinic
trial
may
accur
reflect
specif
pathogenet
substrat
diseas
correl
pattern
observ
clinic
paraclin
paramet
may
ultim
lead
develop
novel
therapeut
strategi
design
target
differ
subtyp
multipl
sclerosi
